A Comparative Analysis of the Clinical Efficacy of Sacubitril Valsartan Sodium and Enalapril in Patients with Non-Valvular Ejection Fraction Reduction in Heart Failure
CONCLUSION: The main findings of the study showed that Sacubitril valsartan sodium showed better clinical efficacy than enalapril in patients with heart failure and non-valvular reduced ejection fraction. Specifically, the drug significantly improved patients' kidney function, reduced cardiovascular marker levels, and reduced the incidence of adverse cardiovascular events. These findings have important clinical implications for guiding treatment selection in patients with heart failure.PMID:38330576
Source: Alternative Therapies in Health and Medicine - Category: Complementary Medicine Authors: Qinqqing Zhang Jiao Wang Yingxiao Da Xin Li Lei Pan Source Type: research
More News: Alternative and Complementary Therapies | Bilirubin | Brain | Cardiology | Cardiovascular | Cholesterol | Complementary Medicine | Diovan | Enalapril | Heart | Heart Failure | Laboratory Medicine | Neurology | Nifedipine | Sodium | Statistics | Study | Urology & Nephrology